The empirical evidence for the presence of a value premium in stock markets is overwhelming. But why does this phenomenon exist? A new white paper examines a popular explanation.
Although there is by now a consensus that a strong value premium is present in the data, the reasons why this phenomenon exists are still heavily debated. In previous research we provided strong evidence against the distress risk explanation, showing that although simple value strategies can get a large exposure to distressed stocks, this does not explain the high return of value stocks.
More risk-based explanations have been proposed in the literature, but next to that there is also a school of thought which attributes the value premium to behavioral factors. In this white paper (download below) we examine one such behavioral explanation, namely the overreaction hypothesis.
According to this hypothesis, value stocks do show lower growth rates in subsequent years, and growth stocks do show higher subsequent growth rates, but not nearly as long and to the extent needed to justify the differences in valuation assigned to them by the market.
We find that although overreaction indicators appear to be fairly promising on a stand-alone basis, they are not really effective for enhancing a generic value strategy. Moreover, if we disentangle the contribution to return of various factors, valuation is significant while the overreaction indicators are not.
This indicates that valuation ratios are really driving differences in future stock returns. Based on these findings we conclude that the empirical support for the overreaction hypothesis is quite weak.
This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.
Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.
The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).
The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.